Discovery of prescopranone, a key intermediate in scopranone biosynthesis

J Antibiot (Tokyo). 2022 Jun;75(6):305-311. doi: 10.1038/s41429-022-00521-x. Epub 2022 Apr 20.

Abstract

A key intermediate in scopranone biosynthesis, prescopranone, accumulated in the mycelium of Streptomyces avermitilis SUKA carrying the biosynthetic gene cluster for scopranone lacking the sprT encoding the monooxygenase. The structure of prescopranone was elucidated by NMR and other spectral data. Prescopranone consists of a 2-pyranone ring with two atypical scoop-like moieties (1-ethyl-1-propenyl and 2-ethylbutyl groups), which was deduced as a product of the modular polyketide syntheses encoded by sprA, sprB, and sprC. Prescopranone inhibited bone morphogenetic protein (BMP)-induced alkaline phosphatase activity in a BMP receptor mutant cell line.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Mixed Function Oxygenases* / genetics
  • Multigene Family*

Substances

  • Mixed Function Oxygenases